Inventor · disambiguated record
David Lickrish
Also filed as: LICKRISH DAVID
23 granted patents·3 pending applications·275 citations·filing 2012–2024
96Inventor score
Top patents by PatentIndex Score
26 records- 0198US9511032B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2016·Granted Dec 6, 2016·15 cites·25 claims
- 0298US9289394B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2015·Granted Mar 22, 2016·18 cites·27 claims
- 0397US10881618B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2020·Granted Jan 5, 2021·5 cites·7 claims
- 0497US9889095B2Methods for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2017·Granted Feb 13, 2018·11 cites·10 claims
- 0597US9603808B2Method of treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2015·Granted Mar 28, 2017·16 cites·17 claims
- 0697US9603809B2Methods of treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2015·Granted Mar 28, 2017·17 cites·28 claims
- 0797US9498447B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2016·Granted Nov 22, 2016·15 cites·22 claims
- 0897US9283214B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2015·Granted Mar 15, 2016·17 cites·29 claims
- 0997US9119809B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2014·Granted Sep 1, 2015·21 cites·29 claims
- 1096US11911518B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2021·Granted Feb 27, 2024·2 cites·8 claims
- 1196US11241391B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2020·Granted Feb 8, 2022·3 cites·14 claims
- 1296US10905652B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2020·Granted Feb 2, 2021·4 cites·7 claims
- 1396US10182995B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2016·Granted Jan 22, 2019·10 cites·9 claims
- 1496US10179108B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2016·Granted Jan 15, 2019·10 cites·8 claims
- 1595US10617651B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2018·Granted Apr 14, 2020·7 cites·9 claims
- 1695US10292937B2Methods of treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2017·Granted May 21, 2019·11 cites·10 claims
- 1794US9023389B1Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2015·Granted May 5, 2015·18 cites·26 claims
- 1893US9034902B2Methods for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2014·Granted May 19, 2015·19 cites·17 claims
- 1993US8916588B2Methods for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2014·Granted Dec 23, 2014·19 cites·29 claims
- 2092US8927010B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2014·Granted Jan 6, 2015·18 cites·28 claims
- 2188US12383506B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2024·Granted Aug 12, 2025·0 cites·9 claims
- 2288US9028868B2Methods and compositions for treatment of attention deficit disorderLICKRISH DAVID·Filed 2012·Granted May 12, 2015·19 cites·14 claims
- 2376US2023120738A1Methylphenidate compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2022·Application pending·0 cites
- 2475US11241392B2Compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2020·Granted Feb 8, 2022·0 cites·14 claims
- 2569US2021275511A1Methylphenidate compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2021·Application pending·0 cites
- 2669US2021267957A1Methylphenidate compositions for treatment of attention deficit hyperactivity disorderIRONSHORE PHARMACEUTICALS & DEV INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Lickrish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →